Buy Gland Pharma, target price Rs 4930: Emkay Global

Emkay Global has buy call on Gland Pharma with a target price of Rs 4930. The current market price of Gland Pharma is Rs 3305. Time period given by analyst is one year when Gland Pharma Ltd. price can reach defined target.

Gland Pharma Ltd., incorporated in the year 1978, is a Small Cap company (having a market cap of Rs 54285.62 Crore) operating in Pharmaceuticals sector.

Gland Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services and Export Incentives for the year ending 31-Mar-2021.



Financials
For the quarter ended 31-12-2021, the company reported a Consolidated Total Income of Rs 1108.99 Crore, down -2.00 % from last quarter Total Income of Rs 1131.67 Crore and up 23.97 % from last year same quarter Total Income of Rs 894.55 Crore. Company reported net profit after tax of Rs 273.03 Crore in latest quarter.

Investment Rationale
The brokerage reiterates Buy rating on Gland Pharma but revise TP to Rs 4,930 from Rs 5,000 due to the removal of a Rs70 vaccine upside. While the company has been making efforts to export, it believes the demand is an issue at this stage for the Sputnik vaccine.

Promoter/FII Holdings
Promoters held 58.0 per cent stake in the company as of 31-Dec-2021, while FIIs owned 11.3 per cent, DIIs 11.66 per cent.